Vanguard Group Inc Exelixis, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 29,307,502 shares of EXEL stock, worth $991 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

29,307,502

Previous 29,654,137 1.17%

Holding current value

$991 Million

Previous $666 Million 14.14%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $7.61 Million - $9.57 Million	-346,635 Reduced 1.17%	29,307,502 $761 Million
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $23.7 Million - $27.7 Million	-1,165,646 Reduced 3.78%	29,654,137 $666 Million
Q1 2024 May 10, 2024	SELL	$20.17 - $23.93 $17.2 Million - $20.4 Million	-851,307 Reduced 2.69%	30,819,783 $731 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $7.7 Million - $9.66 Million	-400,130 Reduced 1.25%	31,671,090 $760 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $14.4 Million - $17.2 Million	-757,695 Reduced 2.31%	32,071,220 $701 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $5.28 Million - $5.95 Million	-290,315 Reduced 0.88%	32,828,915 $627 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $13.5 Million - $16.1 Million	830,216 Added 2.57%	33,119,230 $643 Million
Q4 2022 Feb 10, 2023	BUY	$14.96 - $17.39 $15 Million - $17.5 Million	1,004,182 Added 3.21%	32,289,014 $518 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $3.45 Million - $4.9 Million	220,099 Added 0.71%	31,284,832 $491 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $13.9 Million - $18.4 Million	795,961 Added 2.63%	31,064,733 $647 Million
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $3.56 Million - $4.74 Million	209,083 Added 0.7%	30,268,772 $686 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $718,898 - $993,023	-45,385 Reduced 0.15%	30,059,689 $549 Million
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $2.61 Million - $3.39 Million	160,194 Added 0.53%	30,105,074 $636 Million
Q2 2021 Aug 13, 2021	BUY	$17.95 - $25.56 $538 Million - $765 Million	29,944,880 New	29,944,880 $546 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Exelixis, Inc. Transaction History